1. Home
  2. GERN vs PMT Comparison

GERN vs PMT Comparison

Compare GERN & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.58

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo PennyMac Mortgage Investment Trust of Beneficial Interest

PMT

PennyMac Mortgage Investment Trust of Beneficial Interest

HOLD

Current Price

$11.43

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
GERN
PMT
Founded
1990
2009
Country
United States
United States
Employees
229
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GERN
PMT
Price
$1.58
$11.43
Analyst Decision
Hold
Hold
Analyst Count
3
4
Target Price
$2.17
$13.67
AVG Volume (30 Days)
16.9M
931.2K
Earning Date
05-06-2026
04-21-2026
Dividend Yield
N/A
14.15%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.91
N/A
Revenue Next Year
$43.75
$2.29
P/E Ratio
N/A
$12.59
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$11.17
52 Week High
$2.01
$14.87

Technical Indicators

Market Signals
Indicator
GERN
PMT
Relative Strength Index (RSI) 50.64 34.42
Support Level $1.24 N/A
Resistance Level $1.70 $12.88
Average True Range (ATR) 0.11 0.28
MACD -0.01 -0.02
Stochastic Oscillator 57.81 27.96

Price Performance

Historical Comparison
GERN
PMT

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

Share on Social Networks: